Submucosal tunneling endoscopic resection of upper gastrointestinal tract tumors arising from muscularis propria
- PMID: 28469356
- PMCID: PMC5411376
- DOI: 10.20524/aog.2017.0128
Submucosal tunneling endoscopic resection of upper gastrointestinal tract tumors arising from muscularis propria
Abstract
The management of incidentally discovered small upper gastrointestinal (GI) tract submucosal tumors (SMT) remains debatable. In this review, we summarize the evolving experience with submucosal tunneling endoscopic resection (STER) of upper GI SMTs originating from the muscularis propria. From 16 original studies, we reviewed a total of 703 patients with 736 lesions. Of these, 436 were located in the esophagus, 146 in the esophagogastric junction (EGJ) and 154 in the stomach. The composite complete resection rate (CRR) for STER of upper GI tumors arising from the muscularis propria layer was 99.8% (445/446). The composite CRR for STER of esophageal, EGJ and gastric SMTs arising from the muscularis propria layer was 100% (208/208),100% (78/78)and 100% (115/115), respectively. The composite en bloc resection rate (EBRR) for STER of upper GI tumors arising from the muscularis propria layer was 94.6% (679/718). The composite EBRR for STER of esophageal, EGJ and gastric SMTs arising from the muscularis propria layer was 98.6% (205/208), 96.2% (75/78) and 97.9% (95/97), respectively. Tumor recurrence rate was 0%. The reported complication rate for STER was high but the majority responded to conservative management. STER is a minimally invasive and efficacious alternative to surgery, especially for patients with small tumors (<3 cm). Careful selection of candidates remains crucial for excluding potentially malignant tumors.
Keywords: Submucosal tunneling endoscopic resection; gastrointestinal tumor; muscularis propria.
Conflict of interest statement
Conflict of interest: None
Figures
Similar articles
-
Submucosal tunneling endoscopic resection: An effective and safe therapy for upper gastrointestinal submucosal tumors originating from the muscularis propria layer.World J Gastroenterol. 2019 Jan 14;25(2):245-257. doi: 10.3748/wjg.v25.i2.245. World J Gastroenterol. 2019. PMID: 30670913 Free PMC article.
-
Effect of submucosal tunneling endoscopic resection for submucosal tumors at esophagogastric junction and risk factors for failure of en bloc resection.Surg Endosc. 2018 Mar;32(3):1326-1335. doi: 10.1007/s00464-017-5810-8. Epub 2017 Aug 15. Surg Endosc. 2018. PMID: 28812158
-
Predictors of difficult endoscopic resection of submucosal tumors originating from the muscularis propria layer at the esophagogastric junction.World J Gastrointest Surg. 2022 Sep 27;14(9):918-929. doi: 10.4240/wjgs.v14.i9.918. World J Gastrointest Surg. 2022. PMID: 36185554 Free PMC article.
-
Efficacy and safety of submucosal tunneling endoscopic resection for upper gastrointestinal submucosal tumors with more than 1-year' follow-up: a systematic review and meta-analysis.Scand J Gastroenterol. 2019 Apr;54(4):397-406. doi: 10.1080/00365521.2019.1591500. Epub 2019 Mar 29. Scand J Gastroenterol. 2019. PMID: 30925071
-
Submucosal Tunneling Endoscopic Resection for the Treatment of Gastrointestinal Submucosal Tumors Originating from the Muscularis Propria Layer.J Gastrointest Surg. 2017 Dec;21(12):2100-2109. doi: 10.1007/s11605-017-3579-7. Epub 2017 Oct 17. J Gastrointest Surg. 2017. PMID: 29043576 Review.
Cited by
-
Endoscopic full‑thickness resection with clip‑ and snare‑assisted traction for gastric submucosal tumours in the fundus: A single‑centre case series.Oncol Lett. 2023 Mar 3;25(4):151. doi: 10.3892/ol.2023.13737. eCollection 2023 Apr. Oncol Lett. 2023. PMID: 36936023 Free PMC article.
-
Expanding Role of Third Space Endoscopy in the Management of Esophageal Diseases.Curr Treat Options Gastroenterol. 2018 Mar;16(1):41-57. doi: 10.1007/s11938-018-0169-z. Curr Treat Options Gastroenterol. 2018. PMID: 29435819 Review.
-
Risk stratification in patients with upper gastrointestinal submucosal tumors undergoing submucosal tunnel endoscopic resection.Front Med (Lausanne). 2022 Dec 22;9:1067576. doi: 10.3389/fmed.2022.1067576. eCollection 2022. Front Med (Lausanne). 2022. PMID: 36619638 Free PMC article.
-
Endoscopic Evaluation and Management of Gastric Stromal Tumors.Curr Treat Options Gastroenterol. 2017 Dec;15(4):691-700. doi: 10.1007/s11938-017-0160-0. Curr Treat Options Gastroenterol. 2017. PMID: 29075963 Review.
-
Microscopic positive tumor margin does not increase the rate of recurrence in endoscopic resected gastric mesenchymal tumors compared to negative tumor margin.Surg Endosc. 2020 Jan;34(1):159-169. doi: 10.1007/s00464-019-06744-8. Epub 2019 May 28. Surg Endosc. 2020. PMID: 31139992
References
-
- Lee IL, Lin PY, Tung SY, Shen CH, Wei KL, Wu CS. Endoscopic submucosal dissection for the treatment of intraluminal gastric subepithelial tumors originating from the muscularis propria layer. Endoscopy. 2006;38:1024–1028. - PubMed
-
- American Gastroenterological Association Institute. American Gastroenterological Association Institute medical position statement on the management of gastric subepithelial masses. Gastroenterology. 2006;130:2215–2216. - PubMed
-
- Shi Q, Zhong YS, Yao LQ, Zhou PH, Xu MD, Wang P. Endoscopic submucosal dissection for treatment of esophageal submucosal tumors originating from the muscularis propria layer. Gastrointest Endosc. 2011;74:1194–1200. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials